Language Select


Recent News
Oct 11, 2016

Varian Medical Systems (NYSE: VAR) today announced it will report results for the fourth quarter of fiscal year 2016 following the close of regular trading on Wednesday, Oct. 26, 2016. The...

Sep 26, 2016

Varian Medical Systems (NYSE: VAR) today announced advances in its technology for high definition radiotherapy and radiosurgery. Varian is exhibiting its new HyperArc™ High Definition...

Sep 26, 2016

Varian Medical Systems (NYSE: VAR) today announced the 360 Oncology™ care management platform, the first software system designed to integrate and coordinate key elements of cancer care so...

More news >

Recent Blog Posts
Oct 19, 2016Spot ON
In this Q&A, Dr. Perentesis shares his thoughts on some of the benefits of proton therapy research including reducing side effects and secondary cancers, as well as improving long-term outcomes.
Read more
Oct 5, 2016Spot ON
The Center for Proton Therapy at the Paul Scherrer Institute focuses research on the optimization of treatment delivery and development of innovative treatment concepts. In this Q&A, Dr. Weber offers his insight and experience in proton therapy.
Read more
Sep 21, 2016Spot ON
Highlighted at the Varian Medial Systems' booth #5063 at ASTRO will be the ProBeam® Compact Single-Room Proton Therapy System that offers end-to-end integration, enabling adaptive therapy for better patient care.
Read more
Corporate Communications Contacts
Spencer Sias
Vice President, Corporate Communications and Investor Relations
Mark Plungy
Director, Public Relations
Neil Madle
Director, Corporate Communications/Investor Relations, Europe
+44 (0)7786 526 068
  • Follow Us

Production of any of the material contained herein in any format or media without the express written permission of Varian Medical Systems is prohibited.